KRYS - Krystal Biotech - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KRYS is currently covered by 8 analysts with an average price target of $211. This is a potential upside of $32.9 (18.47%) from yesterday's end of day stock price of $178.1.

Krystal Biotech's activity chart (see below) currently has 54 price targets and 61 ratings on display. The stock rating distribution of KRYS is 96.88% BUY and 3.13% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 96.3% with an average time for these price targets to be met of 298.36 days.

Highest price target for KRYS is $221, Lowest price target is $175, average price target is $211.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 05-Nov-2024. First documented stock forecast 28-Jun-2018.

Currently out of the existing stock ratings of KRYS, 31 are a BUY (96.88%), 1 are a HOLD (3.13%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$221

$50.26 (29.44%)

$221

15 days ago
(05-Nov-2024)

25/27 (92.59%)

$46.59 (26.71%)

199

Buy

$220

$49.26 (28.85%)

$145

2 months 9 days ago
(11-Sep-2024)

2/3 (66.67%)

$21.21 (10.67%)

157

Buy

$180

2 months 22 days ago
(29-Aug-2024)

4/4 (100%)

$65.38 (57.04%)

139

Buy

$175

$4.26 (2.50%)

$130

8 months 24 days ago
(27-Feb-2024)

4/4 (100%)

$4.85 (2.85%)

135

Buy

$153

$-17.74 (-10.39%)

$148

1 years 3 months 13 days ago
(07-Aug-2023)

7/7 (100%)

$44.49 (41.00%)

409

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KRYS (Krystal Biotech) average time for price targets to be met?

On average it took 298.36 days on average for the stock forecasts to be realized with a an average price target met ratio 96.3

Which analyst has the current highest performing score on KRYS (Krystal Biotech) with a proven track record?

JOSH SCHIMMER

Which analyst has the most public recommendations on KRYS (Krystal Biotech)?

Josh Schimmer works at CANTOR FITZGERALD and has 3 price targets and 2 ratings on KRYS

Which analyst is the currently most bullish on KRYS (Krystal Biotech)?

Joseph Pantginis with highest potential upside - $50.26

Which analyst is the currently most reserved on KRYS (Krystal Biotech)?

Wangzhi Li with lowest potential downside - -$66

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?